Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 1.2020.

David S Ettinger,Douglas E Wood,Charu Aggarwal,Dara L Aisner,Wallace Akerley,Jessica R Bauman,Ankit Bharat,Debora S Bruno,Joe Y Chang,Lucian R Chirieac,Thomas A D'Amico,Thomas J Dilling,Michael Dobelbower,Scott Gettinger, Ramaswamy Govindan,Matthew A Gubens,Mark Hennon,Leora Horn,Rudy P Lackner,Michael Lanuti,Ticiana A Leal,Jules Lin,Billy W Loo,Renato G Martins,Gregory A Otterson,Sandip P Patel,Karen L Reckamp,Gregory J Riely,Steven E Schild,Theresa A Shapiro,James Stevenson,Scott J Swanson,Kurt W Tauer,Stephen C Yang,Kristina Gregory,Miranda Hughes

Journal of the National Comprehensive Cancer Network JNCCN（2019）

Cited 571|Views95
No score
Abstract
The NCCN Guidelines for Non-Small Cell Lung Cancer (NSCLC) address all aspects of management for NSCLC. These NCCN Guidelines Insights focus on recent updates in immunotherapy. For the 2020 update, all of the systemic therapy regimens have been categorized using a new preference stratification system; certain regimens are now recommended as "preferred interventions," whereas others are categorized as either "other recommended interventions" or "useful under certain circumstances."
More
Translated text
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined